It was an amazing 2026 planning meeting of the International Lipid Expert Panel

It was an amazing 2026 planning meeting of the International Lipid Expert Panel

Very briefly:1️⃣ Together with Prof. Carlos Escobar and with ILEP as a consortium member, we have just submitted an EU grant on AI applications in CVD medicine for rare and underrepresented diseases. Keep your fingers crossed 👍 2026 is sure to be a year of grants‼️2️⃣ We’re pleased to welcome two new ILEP members: Dr. […]

Lublin Prevention in Cardiovascular Disease SUMMIT 2026 – Program

Lublin Prevention in Cardiovascular Disease SUMMIT 2026 – Program

Lublin Prevention in Cardiovascular Disease SUMMIT 2026 under the umbrella of the International Lipid Expert Panel (ILEP) and the John Paul II Catholic University of Lublin (KUL) 29th January 2026 08:30 – 09:00 Registration, Coffee and Networking 09:00 – 09:05 Lublin and KUL Warm Welcome Prof. Miroslaw Kalinowski (Rector of the KUL) 09:05 – 09:15 […]

Impact of Lipid-Lowering Combination Therapy With Statins and Ezetimibe vs Statin Monotherapy on the Reduction of Cardiovascular Outcomes: A Meta-analysis

Impact of Lipid-Lowering Combination Therapy With Statins and Ezetimibe vs Statin Monotherapy on the Reduction of Cardiovascular Outcomes: A Meta-analysis

Finally, the first and the largest #metaanalysis on the upfront combination lipid lowering therapy (#LLT) of moderate to high intensity #statin therapy and #ezetimibe vs statin monotherapy has been released in the Mayo Clinic Proceedings by Elsevier. Based on the data from 14 studies with 108,373 very high-risk #patients we showed that #combination LLT:👉 significantly […]

PCSK9 and ANGPTL3 Inhibitors in Homozygous Familial Hypercholesterolemia: A Meta‑analysis of Randomized Clinical Trials

PCSK9 and ANGPTL3 Inhibitors in Homozygous Familial Hypercholesterolemia: A Meta‑analysis of Randomized Clinical Trials

Another important International Lipid Expert Panel (ILEP) #metaanalysis on #therapy for homozygous familial #hypercholesterolemia (#HoFH) has just been published in #Drugs (IF = 14.4) by Springer Nature. Excellent work by Prof. Ibadete Bytyçi — ILEP’s Statistical Lead — and the Kosovo team! This is crucial because HoFH remains severely underdiagnosed and is often identified too […]

Lipid management for primary and secondary stroke prevention consensus paper of the International Lipid Expert Panel (ILEP)

Lipid management for primary and secondary stroke prevention consensus paper of the International Lipid Expert Panel (ILEP)

#IschemicStroke is a significant global health challenge, accounting for approximately 66% of all strokes worldwide ‼️ Recent data indicates that stroke was 👉 the third leading cause of death (10.7 % of all deaths), following ischemic heart disease #IHD and #COVID19. In 2021, nearly 94 million people were living with the consequences of a stroke, and […]

It was an important International Lipid Expert Panel online meeting

It was an important International Lipid Expert Panel online meeting

It was an important International Lipid Expert Panel online meeting on Monday evening, with numerous #ILEP#members participated despite being on vacation. Thanks for your commitment! It was so nice to see you all During the meeting, we discussed and agreed for the new composition of the #ILEP#SteeringCommittee for the years 2025-2030, welcoming new SC members […]

Interviews – 10th Anniversary Meeting of ILEP

Interviews – 10th Anniversary Meeting of ILEP

Prof. Dan Gaita Prof. Zeljko Reiner Prof. Arrigo F.G. Cicero Prof. Daniel Pella Prof. Peter P. Toth Prof. Arman Postadzhiyan Prof. Zlatko Fras Prof. Agata Bielecka-Dąbrowa  Prof. Peter E. Penson Prof. Ivan Pecin Prof. Piotr Jankowski